Friday 6 November 2026 Export EFX’s income statement to Excel — free account

Equifax, Inc.

Equifax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 6.92% from fiscal 2024.

Revenue: +9.55%
EPS: +38.5%
Free cash flow: −0.23%
Total debt: +24.5%

Quarter to September 2026, against a year earlier

195.27 3.06 +1.59%

Follow EFX

Alert me

Market cap: $22.7B
P/E: 31.3×
Fwd P/E: 28.3×
Dividend yield: 1.12%
F-score: 8/9
Altman Z: 3.70
Beneish M: −2.84
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Equifax, Inc. (EFX) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by regions, and margins
U.S.	4,661	76.73%
Other	498	8.20%
U.K.	326	5.37%
Australia	318	5.24%
Canada	271	4.47%
Gross margin		56.45%
Operating margin		18.03%
Pre-tax margin		14.73%

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
U.S.	4,661 76.73%	4,327 76.16%	4,036 76.66%	3,983 77.76%	3,822 77.63%	3,173 76.87%	2,502 71.34%	2,405 70.49%	2,380 70.78%	2,291 72.84%
Other	498 8.20%	478 8.41%	386 7.33%	292 5.71%	263 5.34%	237 5.73%	265 7.55%	211 6.18%	218 6.50%	273 8.69%
U.K.	326 5.37%	303 5.33%	266 5.05%	266 5.18%	252 5.12%	223 5.40%	240 6.83%	316 9.27%	311 9.26%	232 7.38%
Australia	318 5.24%	309 5.44%	318 6.03%	325 6.35%	337 6.84%	283 6.85%	290 8.26%	321 9.41%	304 9.04%	214 6.81%
Canada	271 4.47%	265 4.66%	260 4.93%	256 5.00%	250 5.08%	213 5.15%	211 6.01%	159 4.65%	149 4.43%	134 4.27%
Revenue	6,075	5,681	5,265	5,122	4,924	4,128	3,508	3,412	3,362	3,145

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
New Product Vitality Index	Q3 FY2026	17.0%	16.0%	—
Remaining performance obligations	Q3 FY2026	$136.5M	$84.2M	+62.11%

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023	Q4 FY2022	Q3 FY2022	Q2 FY2022	Q1 FY2022	Q4 FY2021	Q3 FY2021	Q2 FY2021	Q1 FY2021	Q4 FY2020	Q3 FY2020	Q2 FY2020	Q1 FY2020	Q4 FY2019	Q3 FY2019	Q2 FY2019	Q1 FY2019	Q4 FY2018	Q3 FY2018	Q2 FY2018	Q1 FY2018
New Product Vitality Index	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Remaining performance obligations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.